Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co LtdfiledCriticalFujisawa Pharmaceutical Co Ltd
Priority to JP57156229ApriorityCriticalpatent/JPS5944325A/ja
Publication of JPS5944325ApublicationCriticalpatent/JPS5944325A/ja
Publication of JPH054074B2publicationCriticalpatent/JPH054074B2/ja
Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof
Monoclonal antibodies for human tissue cross-matching, a diagnostic kit containing them, hybridomas for producing them and a method for producing the hybridomas
Restriction fine specificity of long‐term, hapten‐specific cytotoxic T cell clones: analysis with H‐2Kbm‐mutant mice and H‐2Kb‐specific monoclonal antibodies